Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 3284 entries
View as:

A Study of Tor Kinase Inhibitor in Advanced Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00731263 Org: User:
Start: 07/31/08 End: 11/30/10 Due: 11/30/11

A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT05573464 Org: User:
Start: 09/27/22 End: 03/26/24 Due: 03/26/25

A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration

Phase: N/A Priority: Normal
NCT ID: NCT01755494 Org: User:
Start: 02/28/13 End: 04/30/13 Due: 04/30/14

Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03364608 Org: User:
Start: 12/15/17 End: 03/30/18 Due: 03/30/19

AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)

Phase: N/A Priority: Normal
NCT ID: NCT00808249 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10

Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01006590 Org: User:
Start: 10/31/09 End: 12/31/10 Due: 12/31/11

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

Phase: N/A Priority: Normal
NCT ID: NCT00163436 Org: User:
Start: 09/30/05 End: 01/31/06 Due: 01/31/07

A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).

Phase: N/A Priority: Normal
NCT ID: NCT01153399 Org: User:
Start: 10/31/10 End: 12/31/14 Due: 12/31/15

AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00769899 Org: User:
Start: 10/31/08 End: 03/31/09 Due: 03/31/10

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00214630 Org: User:
Start: 12/31/03 End: 08/31/07 Due: 08/31/08

Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01212601 Org: User:
Start: 01/31/11 End: 11/30/12 Due: 11/30/13

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT00528879 Org: User:
Start: 09/30/07 End: 05/31/10 Due: 05/31/11

Study of Multiple Doses of Saxagliptin (BMS-477118)

Phase: N/A Priority: Normal
NCT ID: NCT00950599 Org: User:
Start: 05/31/03 End: 05/31/04 Due: 05/31/05

Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

Phase: N/A Priority: Normal
NCT ID: NCT01164397 Org: User:
Start: 04/30/09 End: 12/31/10 Due: 12/31/11

Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931

Phase: N/A Priority: Normal
NCT ID: NCT01284595 Org: User:
Start: 03/31/11 End: 05/31/11 Due: 05/31/12

OLE Study to Evaluate Safety / Efficacy of ZD4522

Phase: N/A Priority: Normal
NCT ID: NCT00654303 Org: User:
Start: 08/31/99 End: 02/28/05 Due: 02/28/06

Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05500820 Org: User:
Start: 12/19/19 End: 04/03/20 Due: 04/03/21

A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06795906 Org: User:
Start: 01/28/25 End: 06/27/25 Due: 06/27/26

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Phase: N/A Priority: Normal
NCT ID: NCT05573893 Org: User:
Start: 09/12/23 End: 12/31/31 Due: 12/31/32

An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00684385 Org: User:
Start: - End: - Due: -

Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02843399 Org: User:
Start: 08/15/16 End: 12/15/16 Due: 12/15/17

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06023589 Org: User:
Start: 08/24/23 End: 12/31/27 Due: 12/31/28

Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02917031 Org: User:
Start: 01/10/17 End: 08/23/19 Due: 08/23/20

A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01212575 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00721981 Org: User:
Start: 04/30/09 End: 10/31/09 Due: 10/31/10